ASCO 2023: Precigen reports positive early data for CAR-T therapy

ASCO 2023: Precigen reports positive early data for CAR-T therapy

Source: 
BioSpace
snippet: 

New early data suggests Precigen Therapeutics’s CAR-T therapy PRGN-3005 could decrease tumour burden in advanced ovarian cancer.